Bookmark and Share

BioActivity Data for Target acyl-protein thioesterase 2 [Homo sapiens] [gi:9966764]

BioActivity Outcomes:
Active(70)
 
 
Inactive(201)
 
 
Unspecified(2)
 
 
BioAssay Types:
Confirmatory(11)
 
 
 
 
BioAssay Categories:
Biochemical(247)
 
 
 
 
Cell-based(3)
 
 
 
In vitro(28)
 
 
 
BioActivity Types:
IC50(3)
 
 
 
Substance Types:
Chemical(273)
 
 
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 15    Data Row: 273   Total Pages: 14   Display: Page     
Sort: [Click the result table header to sort]
#StructureSubstanceCompoundActivityBioAssayLinks
OutcomeTypeValue [μM]
1
[SID164117611]
[CID71710938]
0.143Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in situ [AID743119_2, Type: confirmatory]
View
2
[SID160654496]
[CID16193817]
0.144Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP [AID651990_2, Type: confirmatory]
View
3
[SID164117614]
[CID71710927]
0.217Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_2, Type: confirmatory]
View
4
[SID164117611]
[CID71710938]
0.245Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_2, Type: confirmatory]
View
5
[SID164117604]
[CID71710942]
0.258Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_2, Type: confirmatory]
View
6
[SID164117610]
[CID71710929]
0.384Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_2, Type: confirmatory]
View
7
[SID164117613]
[CID71710939]
0.726Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: Fluorescence-based biochemical dose-response gel-based ABPP in vitro [AID743118_2, Type: confirmatory]
View
8
[SID49715467]
[CID24789646]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other]
View
9
[SID92709352]
[CID24792060]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
10
[SID92709358]
[CID7628255]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
11
[SID92709365]
[CID3597028]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
12
[SID92709371]
[CID6520605]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other]
View
13
[SID92709238]
[CID3236902]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
14
[SID92709301]
[CID9548123]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
15
[SID92709325]
[CID4412828]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
16
[SID164117611]
[CID71710938]
Late stage assay provider results from the extended probe development effort to identify inhibitors of LYPLA1 and LYPLA2: LCMS-based cell-based Activity-Based Protein Profiling (ABPP) SILAC selectivity analysis [AID743137_2, Type: other]
View
17
[SID92709345]
[CID1365399]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
18
[SID92709371]
[CID6520605]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
19
[SID92709242]
[CID1343676]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition [AID652029, Type: other]
View
20
[SID49640730]
[CID1130125]
Late stage assay provider results from the probe development effort to identify selective inhibitors of LYPLA2: Fluorescence-based biochemical gel-based ABPP inhibition and selectivity [AID652030_1, Type: other]
View